维普中文期刊产品整合服务
9篇 您的检索式:作者名="Zaier"
    题名 作者 年代 出处 被引量
1Posteroanterior cephalometric norms in Turkish adults显示文摘Tancan U Zaier S 2005AmJorthod2005,127,3:1
2Comparative study of Pb-phytoextraction potential in Sesuvium portulacastrum and Brassica juncea:Tolerance and accumulation显示文摘Zaier H Ghnaya T Lakhdar A 2010Journal of Hazardous Materials2010,183,13:1
3Operational Evaluation of Dynamic Lane Merging In Work Zones with Variable Speed Limits 显示文摘Essam Radwan Zaier Zaidi Rami Harb 2011Procedia-Social and Behavioral Sciences (S1877-0428)2011,16,16:1
4Blind channel estimation enhancement for MIMO-OFDM systems under high mobility conditions显示文摘Aida Zaier Ridha Bouallegue 2012IJWMN2012,4,1:1
5Effects of EDTA on phytoextraction of heavy metals (Zn, Mn and Pb) from sludge-amen- ded soil with Brassica napus 显示文摘Hanen Zaier Tahar Ghnaya Kilani B R 2011Bioresource Technology2011,,:1
6Evaluation of the Cd 2+ phytoextraction potential in the xerohalophyte Salsola kali L. and the impact of EDTA on this process显示文摘Kilani Ben Rejeb Tahar Ghnaya Hanen Zaier Maali Benzarti Raoudha Baioui Rim Ghabriche Meriem Wali Stanley Lutts Chedly Abdelly 2013Ecological Engineering2013,,:1
7EDTA-enhanced phytoremediation of lead-contaminated soil by the halophyte Sesuvium portulacastrum显示文摘Hanen Zaier Tahar Ghnaya Rim Ghabriche Walid Chmingui Abelbasset Lakhdar Stanley Lutts Chedly Abdelly 2014Environmental Science and Pollution Research2014,,12:1
8Energy and Exergy Analyses of a Raw Mill in a Cement Production显示文摘ZaIer Utlu Ziya Sogut Arif Hepbasli 2006Ap- plied Thermal Engineering2006,26,17:1
9Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use显示文摘Dasatinib is a second-line tyrosine kinase inhibitor used in patients with imatinib resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosomepositive acute leukemia. Gastrointestinal bleeding may occur in up to 7% of patients using dasatinib, although, severe dasatinib-related acute colitis had rarely been reported. Here, we present the case of a 36-year-old female who progressed to acute myeloid leukemia after fourteen months of receiving imatinib for CML in the chronic phase and was treated with a dasatinib-containing chemotherapy regimen. On day 34 of treatment, the patient developed moderate abdominal pain and bloody diarrhea with mucous. Analyses of stool specimens were negative for parasites, Clostridium difficile , and other pathogenic bacteria. The cytomegalovirus pp65 antigen was negative in her blood leukocytes. A colonoscopy revealed acute colitis, and a mucosal biopsy showed nonspecific colitis. The patient was treated with broad-spectrum antibiotics, bowel rest and hydration, and dasatinib treatment was stopped. Her bloody diarrhea improved within 72 h. After confirming cytological remission, the patient received initial course of consolidation, and dasatinib treatment was reinstated. However, hemorrhagic colitis recurred. After discontinuing dasatinib, herhemorrhagic colitis drastically improved and did not recur following the administration of nilotinib. The characteristics of our patient suggest that dasatinib treatment can lead to hemorrhagic colitis, which typically resolves after discontinuation of the drug.Zahra Kmira Ben Sayed Nesrine Zaghouani Houneida Ben Fredj Wafa Slama Aida Ben Youssef Yosra Zaier Monia Badreddine Sriha Khelif Abderrahim 2013World Journal of Gastrointestinal Pathophysiology2013,4,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费